NAFDAC Warns Against Counterfeit Cancer Drug, Phesgo
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert regarding a counterfeit cancer treatment drug, Phesgo 600mg/600mg/10ml, with batch number C5290S20. In a statement (Alert No. 051/2024) on its website, NAFDAC revealed that Roche, the drug’s Marketing Authorisation Holder (MAH), flagged the counterfeit batch after receiving a complaint […]
NAFDAC to stop granting licenses for the importation of syringes and needles
The Federal Government has directed the National Agency for Food and Drug Administration and Control (NAFDAC) to stop issuing licenses for the importation of foreign manufactured needles and syringes into the country. Minister of State for Health, Dr Tunji Alausa issued the directive in a circular, mandating all Chief Medical Directors (CMDs) and Medical Directors […]
